Schizophrenia: One Coat of Many Colors by John Smythies
www.frontiersin.org May 2013 | Volume 4 | Article 43 | 1
OpiniOn Article
published: 27 May 2013
doi: 10.3389/fpsyt.2013.00043PSYCHIATRY
leads to excessive methylation and hence 
down regulation of the reelin, GAD67, and 
other genes, resulting in down regulation 
of the GABAergic INs (Grayson et al., 2005; 
Grayson and Guidotti, 2013). The activity of 
Dnmt is regulated by redox factors at several 
levels (Hitchler and Domann, 2012; Kang 
et al., 2012).
S-adenosylmethionine (the universal 
methyl group donor derived from methio-
nine) may also play a role in the chemobiol-
ogy of schizophrenia. It has been known for 
50 years that l-methionine exacerbates the 
symptoms in chronic schizophrenia (Polin 
et al., 1961; Antun et al., 1971). A similar 
result is found in mice treated with excess 
l-methionine, i.e., hypermethylation of the 
reelin gene and the resulting down regula-
tion of reelin and GAD expression (Dong 
et al., 2005). The mice also show decreased 
spine density in frontal cortex. This effect is 
prevented by valproate, which is an inhibi-
tor of DNA methylation (Dong et al., 2010).
DNA methylation and histone acetyla-
tion of the GAD1 gene are heavily influenced 
by the level of maternal care during the neo-
natal and preweaning periods (Zhang et al., 
2010). These workers showed that pups 
reared by high grooming/licking (high-
LG) dams showed enhanced hippocampal 
GAD1 mRNA expression, decreased cyto-
sine methylation, and increased histone 
3-lysine 9 acetylation (H3K9ac) of the 
GAD1 promoter. DNA methyltransferase 
1 expression was significantly higher in the 
offspring of low-compared with high-LG 
mothers. Ketamine effects on PV + neu-
rons are prevented by inhibition of DNA-
methylation (Behrens et al., 2010).
microRNAs
MicroRNAs (miRNA) are short RNAs that 
control the function of their target mes-
senger RNAs by binding to them by base 
shows pronounced changes in expression 
(i.e., low levels of mRNAs) in schizophrenia 
(Benes, 2010).
EpigENEtic pRocEssEs
Epigenetics refers to mechanisms that 
control gene expression without changes 
in DNA sequence and that can be inher-
ited. The mechanisms include DNA meth-
ylation and demethylation, acetylation of 
histones, chromatin-modeling, mRNA 
splicing/editing, and translation, ribosome 
biogenesis and, last but not least, micro-
RNAs (Millan, 2012).
Many of these epigenetic processes 
themselves are controlled by synaptic action 
(Wang and Zhuo, 2012) allowing synaptic 
control of an extensive range of epigenetic 
process, that in turn modulate the protein 
synthesis that is essential for the growth and 
development of synapses, the dendritic tree 
and dendritic spines, neural plasticity, long 
term learning and memory.
In the prefrontal cortex of subjects with 
schizophrenia, excessive DNA methylation 
and abnormal histone methylation, at sites 
of specific genes and promoters, is asso-
ciated with changes in RNA expression 
(Akbarian, 2012). The histone acetylation 
genes and active chromatin remodeling 
are involved in several stages of long term 
memory formation, including consolida-
tion, reconsolidation, and extinction. They 
have also been shown to be abnormal in 
schizophrenia (Kim et al., 2010).
DNA MEthylAtioN
Recently much interest has focused on the 
role of transmethylation of nucleic acid bases 
in schizophrenia. Methylation and demeth-
ylation of cytosine bases in DNA represent 
a prime method of controlling gene expres-
sion. In schizophrenia the DNA methylat-
ing enzyme Dnmt is  over-expressed, which 
iNtRoDuctioN
For a long while the scientific picture of the 
biochemical origins of schizophrenia pre-
sented a large number of apparently quite 
unconnected isolated findings. Recently 
however a clearer account has emerged that 
begins to tie most of these facts together 
into a single coherent account. In other 
words, in most cases, a single complex 
mechanism seems to be involved. The ear-
lier attempts at providing a single hypoth-
esis – for example the transmethylation, 
dopamine (DA), serotonin, redox, and 
glutamate  hypotheses – are coming to be 
seen as parts of an  interlinked whole.
gENEs
The genetic basis of schizophrenia is com-
plex and does not follow the Mendelian 
model. Instead it is based on the interac-
tive effect of a large number of abnormal 
genes each with a single nucleotide poly-
morphism (SNP) and only a minor impact 
(Brennand and Gage, 2011). To give a cou-
ple of examples out of many to illustrate 
the complexity of the system: one recent 
study found 253 SNPs in a population of 92 
schizophrenic patients (Chen et al., 2012). 
Of these SNPs, 138 are known to participate 
in 100 unique genes that regulate four neu-
rotransmitter pathways – GABA receptor 
signaling, DA receptor signaling, neuroreg-
ulin signaling and glutamate receptor sign-
aling – all processes known to be involved 
in schizophrenia. Another group (Ayalew 
et al., 2012), using a different method in a 
large population of schizophrenics, iden-
tified 22 SNPs in genes involved in brain 
development, myelination, cell adhesion, 
glutamate receptor signaling, G-protein-
coupled signaling, and cAMP-mediated 
signaling – all process that have to do with 
interneuronal connectivity. A network of 
genes involved in the regulation of GAD
67
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superoxide- producing enzyme NADPH 
oxidase (Nox2), and leads to oxidative 
damage to fast-spiking parvalbumin posi-
tive GABAergic INs. A number of receptor 
proteins important for glutamatergic trans-
mission are regulated by redox sensitive sites 
(Behrens and Sejnowski, 2009). In adults the 
effects of superoxide activity are quickly or 
slowly reversed. However, damage during 
key period of infancy, especially the second 
postnatal week is never reversed. This dam-
age results in the later post-pubertal failure 
to develop the proper circuits in the brain 
of finely tuned excitation and inhibition 
between the glutamate and GABA sys-
tems. The delay is due to the fact that the 
GABAergic axons are not fully myelinated 
until that age. This results in turn in the 
inability to conduct the complex integra-
tion of synchronized oscillations and to 
cognitive disruption. Fast-spiking INs are 
highly active and therefore may be more 
vulnerable to oxidative damage than other 
cell populations. A related hypothesis was 
presented by Anderson and Maes (2013).
Further research offers more sup-
port for this hypothesis. Nishioka and 
Arnold. (2004) have reported that levels 
of 8-OH-2´deoxyguanosine (an oxidative 
product of DNA) are raised 10-fold in the 
hippocampus of chronic schizophrenics. 
IL-6 is actively transferred across the pla-
centa (Zaretsky et al., 2004). Thus mater-
nally derived proinflammatory cytokines 
could cross the placenta and damage the 
developing fetal brain. Chronic and acute 
maternal stress of different types have been 
associated with increased production of 
proinflammatory cytokines and decreased 
levels of anti-inflammatory ones (Leonard 
and Song, 1998; Maes et al., 1998).
Repetitive administration of the NMDAR 
antagonist ketamine in animals produces 
effects akin to the negative symptoms of 
schizophrenia (Gonzales-Burgos and Lewis, 
2013). This may be because the most sen-
sitive NMDARs to ketamine blockade are 
those located on GABAergic INs. Thus inhi-
bition of these NMDARs will down regu-
late the GABAergic system (Behrens and 
Sejnowski, 2009; Anderson and Maes, 2013). 
This is accompanied with down regulation 
of the GABA synthesis enzyme GAD67 
in PV + INs in rodent brain (Behrens 
and Sejnowski, 2009) and to an enduring 
decrease of inhibitory tone in prefrontal cor-
tex (Zhang et al., 2008). In schizophrenia, 
 pairing and so inhibiting further tran-
scription. They are currently the focus of 
intensive studies in schizophrenia. The most 
reliable findings come from post mortem 
studies. Analysis of global miRNA expres-
sion in postmortem cortical gray matter 
from the superior temporal gyrus revealed 
significant up-regulation of miR-181b 
expression in schizophrenia (Beveridge 
et al., 2008). Increased levels of miR-497 
have been reported in the prefrontal cor-
tex in schizophrenia (Banigan et al., 2013). 
Potkin et al. (2010) have identified risk 
genes with functions related to progenitor 
cell proliferation, migration, and differen-
tiation, cytoskeleton reorganization, axonal 
connectivity, and development of forebrain 
structures. These authors identified in par-
ticular several miRNAs as associated with 
schizophrenia (miRNAs 137, 218, 448).
REEliN
Reelin is an glycoprotein protease secreted 
by certain GABAergic interneurons (INs) 
into the extracellular matrix (Costa et al., 
2002). It is involved in corticogenesis, 
synaptic plasticity, learning, memory, and 
glutamate NMDA receptor regulation. 
Expression of reelin is reduced in schizo-
phrenic brain. MRNA levels for a receptor 
for reelin – very low-density lipoprotein 
receptor (VLDLR) – are reduced in periph-
eral blood lymphocytes of schizophrenic 
patients (Suzuki et al., 2008).
NEuREguliN
Neuregulin (NRG) consists of a family of 
proteins that plays an essential role in several 
neurogenerative processes (Bennett, 2011; 
Ting et al., 2011; Bennett et al., 2012; Fleck 
et al., 2012). The NRG3 variant rs6584400 
is associated with negative symptoms in 
schizophrenia (Meier et al., 2012).
DEvElopMENt of thE uNifyiNg 
hypothEsis
The key to this advance was contained in 
an hypothesis presented by Behrens and 
Sejnowski (2009) and Wang et al. (2013). 
They suggested that the initial step in the 
development of many cases of schizo-
phrenia involved damage to the devel-
oping brain by increased levels of the 
proinflammatory cytokine IL-6 in utero, 
or early in life, derived from such events 
as a maternal viral infection in cases with 
a genetic predisposition. IL-6 activates the 
GABAergic neurons in the prefrontal cortex 
contain lower levels of glutamic acid decar-
boxylase 67 (GAD67) mRNA and protein, as 
well as lower levels of the GABA membrane 
transporter 1 (GAT1) mRNA. The expres-
sion of mRNAs levels for other molecules 
related to the GABA system – neuropeptide 
Y, and vasoactive intestinal peptide – are also 
decreased in postmortem brain, whereas lev-
els of calbindin are increased (Behrens and 
Sejnowski, 2009).
Behrens and Sejnowski (2009) then 
review evidence of increased oxidative 
stress and reduced antioxidant defenses in 
the brain and body tissues in schizophre-
nia. They also review a number of instances 
where this is linked to the increased activity 
of proinflammatory cytokines. They cite the 
finding by Smith et al. (2007), using a rodent 
maternal-infection model, that excess 
maternal IL-6 so induced results in delayed 
schizophrenia-like behavior observed in the 
adult offspring. Further experiments show 
that prolonged blockade of NMDA-Rs in 
PV-INs results in an enduring change in 
AMPA and mGluR5-mediated responses 
to glutamate (Behrens et al., 2007).
Prenatal exposure of rats to the viral 
mimic Poly-I:C induced delayed postnatal 
changes in basal neurotransmitter levels, 
including reduced DA and glutamate con-
tents in the prefrontal cortex and hippocam-
pus, as well as to deficits in social interaction 
and anhedonic behavior (Bitanihirwe et al., 
2010). Growing evidence from clinical stud-
ies with COX-2 inhibitors points to favora-
ble effects of anti-inflammatory therapy in 
schizophrenia (Müller et al., 2012).
Environmental factors, such as viral 
infections, inflammation, and obstetri-
cal complications, as well as psychologi-
cal stress, are closely associated with an 
increase in oxidative stress (Liu et al., 1996; 
Lante et al., 2007), and are considered risk 
factors for schizophrenia (Watson et al., 
1984; Brown, 2006, 2011). Social isola-
tion rearing in rats induces behavioral 
and redox changes akin to schizophrenia 
(Smythies, 1999; Heidbreder et al., 2000; 
Andreas et al., 2004). In a study of the 
effects of 8 weeks social isolation rearing on 
cortico-striatal redox reactions and social 
and cognitive behaviors in rats, Möller 
et al. (2011) found increased superoxide 
production, decreased levels of the key 
antioxidant glutathione, and increased 
lipid peroxidation in several regions, as well 
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would diminish the levels of these mole-
cules in the brain. This central mechanism 
may activate further signaling chains that 
involve other brain mechanisms, such as 
the DA and serotonin systems, lipid per-
oxidation, etc. Exigencies of space preclude 
discussion of these earlier hypotheses in 
any detail. One key point still to be clarified 
(that has possible therapeutic implications) 
is to what extent is down regulation of the 
GABAergic system by oxidative stress due 
to an irreversible oxidative attack on neural 
proteins, lipids, and DNA, or to what extent 
is it the result of potentially reversible DNA 
methylation and histone modifications.
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syNchRoNizED gAMMA 
oscillAtioNs
Precisely timed interactions between excita-
tory cortical pyramidal cells and inhibitory 
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factors in the synchronization of gamma 
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coNclusioN
The present picture of schizophrenia starts 
with intrauterine or early postnatal dam-
age to the developing fetal brain by a num-
ber of environmental factors, mediated in 
part by a signaling chain that links cytokine 
IL-6 and superoxide toxicities in genetically 
predisposed subjects. These factors focus 
upon, and disrupt, (1) the function of 
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prefrontal cortex and (2) DNA methyla-
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These in turn would impair the synchro-
nized oscillations that link PV + INs and 
P cells in the cortex needed for effective 
cognition. Excess DNA methylation of the 
genes for GABAergic relevant molecules 
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